Krishna Institute of Medical Sciences Ltd (KIMS) Q4FY26 Concall Summary - Mar-2026 Qtr
Performance Overview
- The company reported stable growth for the quarter, driven significantly by the top-line contributions from new units in Bangalore, Thane, Kerala, Nasik, and Vizag, while mature units maintained a healthy growth pattern.
- Operational parameters demonstrated a consistent upward trend, with notable quarterly growth in average revenue per operating bed (ARPOB), average revenue per patient (ARPP), and both inpatient (IP) and outpatient (OP) volumes.
- Profitability was impacted during the quarter due to the heavy initial expenditures and EBITDA drag associated with the newly commissioned hospitals, which are still in the ramp-up phase.
- The company has been in a significant expansion phase, opening multiple new hospitals and facility centers across Hyderabad, Guntur, Maharashtra, Bangalore, and Kerala, reflecting its strategy of strengthening its presence in core and new markets.
- Management highlighted that the primary challenge affecting the ramp-up of new units has been the delay in securing insurance empanelments, a situation exacerbated by recent changes in the industry's empanelment process involving the General Insurance Council (GIC).
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.